Intermediate Fibroblastic Neoplasm — Trials

Intermediate Fibroblastic Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

128 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02465528	Ceritinib Rare Indications Study in ALK+ Tumors	terminated	Phase 2	22	Novartis PharmaceuticalsINDUSTRY	8	Dec 27, 2019	clinicaltrials
NCT01059656	Phase II Pazopanib Study in Advanced Dermatofibrosarcomas(DFSP-PAZO)	terminated	Phase 2	23	Assistance Publique - Hôpitaux de ParisOTHER	1	Jul 1, 2016	clinicaltrials